4//SEC Filing
Donley Matthew Maxwell 4
Accession 0001628280-22-030745
CIK 0001600620other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:04 PM ET
Size
4.7 KB
Accession
0001628280-22-030745
Insider Transaction Report
Form 4
Donley Matthew Maxwell
Chief Operating Officer
Transactions
- Purchase
Common Stock
2022-11-21$4.66/sh+10,000$46,600→ 27,927 total
Footnotes (1)
- [F1]Includes 1,703 common stock of the Issuer acquired by the reporting person on May 31, 2022 pursuant to the Company's 2021 Employee Stock Purchase Plan.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001636642
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:04 PM ET
- Size
- 4.7 KB